drugset / Trial / NCT02518373
Effect of G17DT in Patients With Stage II/III Colorectal Cancer
NaSingle-groupOpen-labelTreatment
Summary
This Phase 2 study was an open label, single-center 18-week study to compare basal and meal stimulated plasma gastrin levels before and after treatment with 3 intramuscular injections of 250 µg G17DT, with and without the concomitant administration of Omeprazole.
Timeline
- Start
- 2000-04
- Primary completion
- 2001-02
- Completion
- 2001-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | G17DT Immunogen | Vaccine | 250 ug | Intramuscular |
| Subject | Omeprazole | Other / unclassified | — | — |